North America is considered to be the largest market for cardiac output monitoring devices due to factors, such as the growing aging population, prevalence of various cardiovascular diseases, and increasing healthcare infrastructure facilities. It is expected that there will be a two-fold rise in the aging population by 2025, thereby increasing the requirement of medical treatment. The rising average life expectancy of the population is expected to fuel the growth of the healthcare expenditure, which is consequently projected to boost the cardiac output monitoring devices market.
Ask for Discount @ http://www.micromarketmonitor.com/contact/7375636233-ask_for_discount.html
The U.S. accounted for the largest share in the North American cardiac output monitoring devices market. The huge medical infrastructure facility, with around 25,000 critical care beds per 100,000 capita, and the presence of one of the key players; Pulsion Medical Systems SE, with minimal or non-invasive cardiac output facilities has accelerated the U.S. market growth.
Speak to Analyst @ http://www.micromarketmonitor.com/contact/7375636233-speak_to_analyst.html
Canada is the second-largest market in the cardiac output monitoring devices in North America. The growth in the market is due to the presence of ambulatory care facilities. Also, the minimally invasive cardiac output monitoring device market in Mexico has witnessed substantial growth in the recent years. A number of companies, such as Deltex Medial, LiDCO Group PLC have excellent growth opportunities in the minimally invasive cardiac output solutions segment, while Cheetah Medical with non-invasive bioimpedance technology is also experiencing high growth in the market. Mexico has a developed healthcare system, where National Health Services (NHS) follows a universal concept of coverage and all citizens are entitled to healthcare services that are free at the point-of-care centers.
